Enigmol: A Novel Sphingolipid Analogue with Anticancer Activity against Cancer Cell Lines and In vivo Models for Intestinal and Prostate Cancer

H Symolon, A Bushnev, Q Peng, H Ramaraju… - Molecular cancer …, 2011 - AACR
Sphingoid bases are cytotoxic for many cancer cell lines and are thought to contribute to
suppression of intestinal tumorigenesis in vivo by ingested sphingolipids. This study …
被引用次数：66 相关文章

Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer

H Symolon, A Bushnev, Q Peng… - Molecular cancer …, 2011 - pubmed.ncbi.nlm.nih.gov
Sphingoid bases are cytotoxic for many cancer cell lines and are thought to contribute to
suppression of intestinal tumorigenesis in vivo by ingested sphingolipids. This study …

Enigmol: A Novel Sphingolipid Analogue with Anticancer Activity against Cancer Cell Lines and In vivo Models for Intestinal and Prostate Cancer

H Symolon, A Bushnev, Q Peng, H Ramaraju… - Molecular Cancer …, 2011 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Sphingoid bases are cytotoxic for many cancer
cell lines and are thought to contribute to suppression of intestinal tumorigenesis in vivo by …

Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer.

H Symolon, A Bushnev, Q Peng… - Molecular Cancer …, 2011 - europepmc.org
Sphingoid bases are cytotoxic for many cancer cell lines, and are thought to contribute to
suppression of intestinal tumorigenesis in vivo by ingested sphingolipids. This study …
[HTML] nih.gov

[HTML][HTML] Enigmol: A novel sphingolipid analog with anti-cancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer

H Symolon, A Bushnev, Q Peng… - Molecular cancer …, 2011 - ncbi.nlm.nih.gov
Sphingoid bases are cytotoxic for many cancer cell lines, and are thought to contribute to
suppression of intestinal tumorigenesis in vivo by ingested sphingolipids. This study …

Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer.

H Symolon, A Bushnev, Q Peng… - Molecular Cancer …, 2011 - europepmc.org
Sphingoid bases are cytotoxic for many cancer cell lines, and are thought to contribute to
suppression of intestinal tumorigenesis in vivo by ingested sphingolipids. This study …